Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
Pharma
J&J's Imaavy wins FDA green light in myasthenia gravis
The FDA on Wednesday approved J&J’s nipocalimab under the brand name Imaavy as a new treatment for generalized myasthenia gravis.
Fraiser Kansteiner
Apr 30, 2025 10:51am
J&J puts ImmunityBio on defense mode in bladder cancer
Apr 27, 2025 12:35pm
Top 20 pharma companies by 2024 revenue
Apr 21, 2025 3:00am
J&J lifts 2025 sales guidance despite looming tariff threat
Apr 15, 2025 11:55am
Novo’s Wegovy, J&J’s Tremfya led March TV ad spending totals
Apr 7, 2025 11:21am
Viatris settles opioid claims, agreeing to pay up to $335M
Apr 7, 2025 10:48am
